Revvity (RVTY) Stock Forecast, Price Target & Predictions
RVTY Stock Forecast
Revvity stock forecast is as follows: an average price target of $133.80 (represents a 8.32% upside from RVTY’s last price of $123.52) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.
RVTY Price Target
RVTY Analyst Ratings
Buy
Revvity Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jan 21, 2025 | Andrew Cooper | Raymond James | $140.00 | $116.60 | 20.07% | 13.34% |
Jan 10, 2025 | Eve Burstein | Bernstein | $130.00 | $113.88 | 14.16% | 5.25% |
Nov 04, 2024 | Paul Knight | KeyBanc | $132.00 | $124.82 | 5.75% | 6.87% |
Oct 15, 2024 | Luke Sergott | Barclays | $140.00 | $122.91 | 13.90% | 13.34% |
Jul 30, 2024 | Derik de Bruin | Bank of America Securities | $127.00 | $125.59 | 1.12% | 2.82% |
Jul 29, 2024 | Tycho Peterson | Jefferies | $125.00 | $125.29 | -0.23% | 1.20% |
Jul 29, 2024 | Daniel Arias | Stifel Nicolaus | $110.00 | $120.16 | -8.46% | -10.95% |
Jul 29, 2024 | Patrick Donnelly | Citigroup | $135.00 | $120.16 | 12.35% | 9.29% |
Jul 29, 2024 | Vijay Kumar | Evercore ISI | $126.00 | $120.16 | 4.86% | 2.01% |
Apr 29, 2024 | Dan Leonard | UBS | $120.00 | $105.02 | 14.26% | -2.85% |
Revvity Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 2 | 3 | 10 |
Avg Price Target | $135.00 | $134.00 | $128.50 |
Last Closing Price | $123.52 | $123.52 | $123.52 |
Upside/Downside | 9.29% | 8.48% | 4.03% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jan 21, 2025 | Raymond James | Outperform | Outperform | Hold |
Jan 10, 2025 | Bernstein | Market Perform | Downgrade | |
Nov 04, 2024 | KeyBanc | Overweight | Overweight | Hold |
Oct 15, 2024 | Barclays | Equal-Weight | Overweight | Upgrade |
Aug 27, 2024 | Wells Fargo | Equal-Weight | Initialise | |
Jul 30, 2024 | Cowen & Co. | Buy | Buy | Hold |
Jul 30, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
Jul 30, 2024 | Bank of America Securities | Neutral | Neutral | Hold |
Jul 29, 2024 | Jefferies | Hold | Hold | Hold |
Jul 29, 2024 | Citigroup | Buy | Buy | Hold |
Jul 29, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Apr 30, 2024 | Cowen & Co. | Buy | Buy | Hold |
Apr 29, 2024 | UBS | Neutral | Neutral | Hold |
Revvity Financial Forecast
Revvity Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $674.87M | $741.21M | $711.80M | $1.23B | $1.26B | $1.36B | $1.17B | $1.23B | $1.31B | $1.35B | $964.02M | $811.72M | $652.40M | $805.50M | $706.92M |
Avg Forecast | $820.85M | $754.84M | $764.06M | $713.21M | $761.90M | $711.13M | $714.51M | $669.05M | $728.05M | $679.66M | $690.33M | $647.25M | $677.13M | $695.40M | $708.38M | $678.90M | $1.03B | $1.02B | $1.20B | $1.19B | $1.27B | $1.04B | $1.12B | $1.21B | $1.23B | $840.15M | $722.01M | $649.26M | $801.08M | $721.38M |
High Forecast | $834.90M | $767.76M | $777.14M | $725.41M | $774.94M | $723.30M | $726.74M | $675.98M | $731.85M | $679.73M | $690.33M | $647.45M | $682.85M | $706.09M | $720.50M | $690.52M | $1.04B | $1.02B | $1.20B | $1.19B | $1.27B | $1.04B | $1.12B | $1.21B | $1.23B | $840.15M | $722.01M | $649.26M | $801.08M | $721.38M |
Low Forecast | $798.35M | $734.15M | $743.12M | $693.66M | $741.02M | $691.64M | $694.93M | $654.35M | $723.10M | $679.58M | $690.32M | $647.04M | $669.72M | $685.27M | $688.96M | $660.30M | $1.01B | $1.02B | $1.20B | $1.19B | $1.27B | $1.04B | $1.12B | $1.21B | $1.23B | $840.15M | $722.01M | $649.26M | $801.08M | $721.38M |
# Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 7 | 5 | 3 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 0.72% | 0.70% | 1.02% | 1.06% | 1.07% | 1.12% | 1.09% | 1.08% | 1.11% | 1.15% | 1.12% | 1.00% | 1.01% | 0.98% |
Forecast
Revvity EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 7 | 5 | 3 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $158.42M | $266.62M | $220.69M | $380.02M | $391.55M | $465.46M | $313.89M | $414.87M | $551.24M | $546.42M | $312.35M | $236.86M | $114.97M | $170.25M | $147.27M |
Avg Forecast | $249.87M | $229.78M | $232.59M | $217.11M | $231.93M | $216.47M | $217.50M | $203.66M | $221.62M | $206.89M | $210.14M | $197.03M | $206.13M | $211.68M | $215.64M | $206.66M | $313.19M | $305.05M | $359.56M | $355.16M | $380.39M | $310.97M | $335.36M | $361.69M | $365.93M | $250.95M | $215.67M | $193.94M | $239.28M | $215.48M |
High Forecast | $254.15M | $233.71M | $236.57M | $220.82M | $235.90M | $220.18M | $221.23M | $205.77M | $222.78M | $206.92M | $210.14M | $197.09M | $207.86M | $214.94M | $219.33M | $210.20M | $316.68M | $305.05M | $359.56M | $355.16M | $380.39M | $310.97M | $335.36M | $361.69M | $365.93M | $250.95M | $215.67M | $193.94M | $239.28M | $215.48M |
Low Forecast | $243.03M | $223.48M | $226.21M | $211.16M | $225.57M | $210.54M | $211.54M | $199.19M | $220.12M | $206.87M | $210.14M | $196.96M | $203.87M | $208.60M | $209.73M | $201.00M | $306.94M | $305.05M | $359.56M | $355.16M | $380.39M | $310.97M | $335.36M | $361.69M | $365.93M | $250.95M | $215.67M | $193.94M | $239.28M | $215.48M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.77% | 0.85% | 0.72% | 1.06% | 1.10% | 1.22% | 1.01% | 1.24% | 1.52% | 1.49% | 1.24% | 1.10% | 0.59% | 0.71% | 0.68% |
Forecast
Revvity Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 7 | 5 | 3 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $24.84M | $107.50M | $85.35M | $179.21M | $176.96M | $179.18M | $127.74M | $245.93M | $379.31M | $380.36M | $176.70M | $137.16M | $33.66M | $64.50M | $58.56M |
Avg Forecast | $197.62M | $170.25M | $173.32M | $150.74M | $175.90M | $152.93M | $153.44M | $131.57M | $168.31M | $138.57M | $138.02M | $115.96M | $143.29M | $146.85M | $146.25M | $122.86M | $201.61M | $177.82M | $248.69M | $261.16M | $277.54M | $214.86M | $300.90M | $381.43M | $371.86M | $185.64M | $104.51M | $68.78M | $163.69M | $124.55M |
High Forecast | $202.02M | $174.04M | $177.18M | $154.09M | $179.82M | $156.33M | $156.85M | $137.49M | $172.02M | $138.59M | $138.03M | $116.36M | $147.02M | $154.26M | $146.47M | $125.59M | $204.54M | $177.82M | $248.69M | $261.16M | $277.54M | $214.86M | $300.90M | $381.43M | $371.86M | $185.64M | $104.51M | $68.78M | $163.69M | $124.55M |
Low Forecast | $190.58M | $164.19M | $167.15M | $145.36M | $169.64M | $147.48M | $147.97M | $124.45M | $163.36M | $138.55M | $138.01M | $115.55M | $142.04M | $141.92M | $146.04M | $118.48M | $196.39M | $177.82M | $248.69M | $261.16M | $277.54M | $214.86M | $300.90M | $381.43M | $371.86M | $185.64M | $104.51M | $68.78M | $163.69M | $124.55M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.20% | 0.53% | 0.48% | 0.72% | 0.68% | 0.65% | 0.59% | 0.82% | 0.99% | 1.02% | 0.95% | 1.31% | 0.49% | 0.39% | 0.47% |
Forecast
Revvity SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 7 | 5 | 3 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $248.56M | $244.32M | $239.97M | $330.02M | $334.39M | $355.25M | $339.05M | $281.82M | $251.41M | $263.05M | $225.25M | $221.03M | $208.57M | $210.74M | $204.17M |
Avg Forecast | $237.89M | $218.76M | $221.43M | $206.69M | $220.81M | $206.09M | $207.07M | $193.90M | $211.00M | $196.97M | $200.06M | $187.58M | $196.24M | $201.53M | $205.30M | $196.75M | $298.17M | $268.86M | $316.90M | $313.02M | $335.26M | $274.08M | $295.57M | $318.77M | $322.52M | $221.18M | $190.08M | $170.93M | $210.89M | $189.91M |
High Forecast | $241.96M | $222.50M | $225.22M | $210.23M | $224.59M | $209.62M | $210.62M | $195.91M | $212.10M | $196.99M | $200.06M | $187.64M | $197.90M | $204.63M | $208.81M | $200.12M | $301.50M | $268.86M | $316.90M | $313.02M | $335.26M | $274.08M | $295.57M | $318.77M | $322.52M | $221.18M | $190.08M | $170.93M | $210.89M | $189.91M |
Low Forecast | $231.37M | $212.76M | $215.36M | $201.03M | $214.75M | $200.44M | $201.40M | $189.64M | $209.56M | $196.95M | $200.06M | $187.52M | $194.09M | $198.60M | $199.67M | $191.36M | $292.22M | $268.86M | $316.90M | $313.02M | $335.26M | $274.08M | $295.57M | $318.77M | $322.52M | $221.18M | $190.08M | $170.93M | $210.89M | $189.91M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.26% | 0.82% | 0.89% | 1.04% | 1.07% | 1.06% | 1.24% | 0.95% | 0.79% | 0.82% | 1.02% | 1.16% | 1.22% | 1.00% | 1.08% |
Forecast
Revvity EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 7 | 5 | 3 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.20 | $0.85 | $0.68 | $1.42 | $1.40 | $1.42 | $1.12 | $2.20 | $3.39 | $3.40 | $1.58 | $1.23 | $0.30 | $0.58 | $0.53 |
Avg Forecast | $1.61 | $1.38 | $1.41 | $1.23 | $1.43 | $1.24 | $1.25 | $1.07 | $1.37 | $1.13 | $1.12 | $0.94 | $1.16 | $1.19 | $1.19 | $1.00 | $1.64 | $1.44 | $2.01 | $2.12 | $2.25 | $1.74 | $2.44 | $3.09 | $3.01 | $1.50 | $0.85 | $0.56 | $1.33 | $1.01 |
High Forecast | $1.64 | $1.41 | $1.44 | $1.25 | $1.46 | $1.27 | $1.27 | $1.12 | $1.40 | $1.13 | $1.12 | $0.95 | $1.20 | $1.25 | $1.19 | $1.02 | $1.66 | $1.44 | $2.01 | $2.12 | $2.25 | $1.74 | $2.44 | $3.09 | $3.01 | $1.50 | $0.85 | $0.56 | $1.33 | $1.01 |
Low Forecast | $1.55 | $1.33 | $1.36 | $1.18 | $1.38 | $1.20 | $1.20 | $1.01 | $1.33 | $1.13 | $1.12 | $0.94 | $1.15 | $1.15 | $1.19 | $0.96 | $1.60 | $1.44 | $2.01 | $2.12 | $2.25 | $1.74 | $2.44 | $3.09 | $3.01 | $1.50 | $0.85 | $0.56 | $1.33 | $1.01 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.20% | 0.52% | 0.47% | 0.71% | 0.66% | 0.63% | 0.64% | 0.90% | 1.10% | 1.13% | 1.05% | 1.45% | 0.54% | 0.44% | 0.53% |
Forecast
Revvity Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
ACRS | Aclaris Therapeutics | $2.36 | $6.00 | 154.24% | Buy |
ICLR | ICON Public | $198.12 | $337.00 | 70.10% | Buy |
NEOG | Neogen | $11.50 | $17.50 | 52.17% | Buy |
IQV | IQVIA | $198.07 | $249.63 | 26.03% | Buy |
CRL | Charles River Laboratories | $161.64 | $201.50 | 24.66% | Buy |
IDXX | IDEXX Laboratories | $418.75 | $479.75 | 14.57% | Buy |
QGEN | Qiagen | $43.77 | $49.00 | 11.95% | Buy |
RVTY | Revvity | $123.52 | $133.80 | 8.32% | Buy |
MEDP | Medpace | $343.02 | $369.67 | 7.77% | Hold |
MTD | Mettler-Toledo | $1.34K | $1.41K | 5.77% | Hold |
LH | Laboratory Corporation of America | $246.22 | $258.20 | 4.87% | Buy |
A | Agilent | $147.09 | $150.50 | 2.32% | Buy |
TWST | Twist Bioscience | $49.52 | $46.00 | -7.11% | Buy |
WAT | Waters | $404.17 | $371.00 | -8.21% | Buy |